Epic Research Update : Sun Pharmaceutical Industries

Sun Pharmaceutical Industries has entered into definitive agreements with Ranbaxy Laboratories pursuant to which Sun Pharma will acquire 100% of Ranbaxy in an all-stock transaction. Under these agreements, Ranbaxy shareholders will receive 0.8 share of Sun Pharma for each share of Ranbaxy.

For more information ✆ - 0731-6642300 or Visit http://ift.tt/1doLhaI

Posted in: Indian Market Tips